[go: up one dir, main page]

WO1998034598A3 - Formulations homogenes sous forme de granules destinees a la technologie d'aspiration des doses - Google Patents

Formulations homogenes sous forme de granules destinees a la technologie d'aspiration des doses Download PDF

Info

Publication number
WO1998034598A3
WO1998034598A3 PCT/EP1998/000797 EP9800797W WO9834598A3 WO 1998034598 A3 WO1998034598 A3 WO 1998034598A3 EP 9800797 W EP9800797 W EP 9800797W WO 9834598 A3 WO9834598 A3 WO 9834598A3
Authority
WO
WIPO (PCT)
Prior art keywords
granulated formulations
homogeneous granulated
dose sipping
technology
sipping technology
Prior art date
Application number
PCT/EP1998/000797
Other languages
English (en)
Other versions
WO1998034598A2 (fr
Inventor
Jan Willem Groenendaal
Original Assignee
Gist Brocades Bv
Jan Willem Groenendaal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Bv, Jan Willem Groenendaal filed Critical Gist Brocades Bv
Priority to AU64964/98A priority Critical patent/AU6496498A/en
Publication of WO1998034598A2 publication Critical patent/WO1998034598A2/fr
Publication of WO1998034598A3 publication Critical patent/WO1998034598A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

On a élaboré un certain nombre de formulations homogènes sous forme de granulés destinées à la technologie d'aspiration des doses, qu'on utilise pour administrer une matière pharmaceutiquement active telle que par exemple des agents anti-infectieux comme des antibiotiques antibactériens qui sont co-formulés avec un certain nombre d'excipients.
PCT/EP1998/000797 1997-02-07 1998-02-06 Formulations homogenes sous forme de granules destinees a la technologie d'aspiration des doses WO1998034598A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU64964/98A AU6496498A (en) 1997-02-07 1998-02-06 Homogeneous granulated formulations for dose sipping technology

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200327.1 1997-02-07
EP97200327 1997-02-07

Publications (2)

Publication Number Publication Date
WO1998034598A2 WO1998034598A2 (fr) 1998-08-13
WO1998034598A3 true WO1998034598A3 (fr) 1998-11-19

Family

ID=8227990

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/000797 WO1998034598A2 (fr) 1997-02-07 1998-02-06 Formulations homogenes sous forme de granules destinees a la technologie d'aspiration des doses

Country Status (2)

Country Link
AU (1) AU6496498A (fr)
WO (1) WO1998034598A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
WO2020021111A1 (fr) * 2018-07-27 2020-01-30 Sisteks D.O.O. Paille pour administration orale de formulation pharmaceutique

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2251250A1 (de) * 1972-10-19 1974-05-02 Hoechst Ag Verfahren zur herstellung hochdosierter antibiotica-tabletten
EP0281200A1 (fr) * 1987-03-02 1988-09-07 Yamanouchi Europe B.V. Composition pharmaceutique, granulé pharmaceutique et leur procédé de fabrication
US4792333A (en) * 1986-11-04 1988-12-20 Strawdose, Inc. Unit dose drug package and administering device
US4981468A (en) * 1989-02-17 1991-01-01 Eli Lilly And Company Delivery device for orally administered therapeutic agents
WO1991016893A1 (fr) * 1990-04-27 1991-11-14 Beecham Group Plc Formulation pharmaceutique
WO1992019227A2 (fr) * 1991-05-08 1992-11-12 Laboratorios Beecham Sa Preparations pharmaceutiques
WO1995028927A1 (fr) * 1994-04-23 1995-11-02 Smithkline Beecham Corporation Comprime enrobe d'un polymere, comprenant de l'amoxycilline et du clavulanate
WO1997003634A1 (fr) * 1995-07-21 1997-02-06 Alza Corporation Administration d'unites discretes par voie orale

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2251250A1 (de) * 1972-10-19 1974-05-02 Hoechst Ag Verfahren zur herstellung hochdosierter antibiotica-tabletten
US4792333A (en) * 1986-11-04 1988-12-20 Strawdose, Inc. Unit dose drug package and administering device
EP0281200A1 (fr) * 1987-03-02 1988-09-07 Yamanouchi Europe B.V. Composition pharmaceutique, granulé pharmaceutique et leur procédé de fabrication
US4981468A (en) * 1989-02-17 1991-01-01 Eli Lilly And Company Delivery device for orally administered therapeutic agents
WO1991016893A1 (fr) * 1990-04-27 1991-11-14 Beecham Group Plc Formulation pharmaceutique
WO1992019227A2 (fr) * 1991-05-08 1992-11-12 Laboratorios Beecham Sa Preparations pharmaceutiques
WO1995028927A1 (fr) * 1994-04-23 1995-11-02 Smithkline Beecham Corporation Comprime enrobe d'un polymere, comprenant de l'amoxycilline et du clavulanate
WO1997003634A1 (fr) * 1995-07-21 1997-02-06 Alza Corporation Administration d'unites discretes par voie orale

Also Published As

Publication number Publication date
WO1998034598A2 (fr) 1998-08-13
AU6496498A (en) 1998-08-26

Similar Documents

Publication Publication Date Title
AU7305594A (en) Physiologically active substance-prolonged releasing-type pharmaceutical preparation
CA2102630A1 (fr) Compositions pharmaceutiques de medicaments compactes
AU1471701A (en) Multiple precision dose, preservative-free medication delivery system
AU3616295A (en) Pharmaceutically active substituted aromatic compounds
EP0595133A3 (fr) Prodroques, leur préparation, et utilisation comme médicaments
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
WO2001035941A8 (fr) Nouvelle composition et utilisation
HUP9900028A3 (en) Pharmaceutically active quinazoline compounds, their production, use thereof and medicament containing them
AU4399196A (en) Intravaginal drug delivery devices for the administration of 17beta -oestradiol precursors
AU6062590A (en) Pharmaceutically active compounds
AU6075198A (en) Drug delivery system for two or more active substances
EP0995434A3 (fr) Formulations d'aérosols à usage médical
AU5402296A (en) Pharmaceutical composition for transdermic administration
DE69631609D1 (en) Tricyclische erythromycinderivate
AU7840994A (en) Active substance delivery system
MXPA03009391A (es) METODO PARA FABRICAR UNA COMPOSICIoN FARMACEUTICA DE DOSIS BAJA.
WO1998038983A3 (fr) Comprimes a avaler contenant du paracetamol
AU5290199A (en) Erythromycin derivatives with antibiotic activity
AU2080199A (en) New pharmaceutically active compounds
AU5965399A (en) Pharmaceutically active composition
AU4628993A (en) Physiologically active peptide composition
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
WO1998034598A3 (fr) Formulations homogenes sous forme de granules destinees a la technologie d'aspiration des doses
IE873091L (en) Optically active gyrase inhibitors, their preparation and¹use as antibiotics
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA